Digital Power Corporation® Awarded $50 Million Purchase Order
Mar 15, 2017 10:55 am UTC| Business
Largest Order in the Company’s History from Manufacturer of Disruptive Technology FREMONT, Calif., March 15, 2017 -- Digital Power Corporation (NYSE Mkt:DPW) has been awarded a 3-year, $50 million purchase order by...
Mar 15, 2017 10:45 am UTC| Business
CINCINNATI, March 15, 2017 -- LSI Industries Inc. (NASDAQ:LYTS) today announced the appointment of Howard (“Howie”) E. Japlon to the position of Executive Vice President, Human Resources and General Counsel, effective...
Mar 15, 2017 10:30 am UTC| Business
IRVING, Texas, March 15, 2017 -- Global Power Equipment Group Inc. (OTC:GLPW) (“Global Power” or the “Company”) will release its 2015 results and restated prior periods after the close of financial markets on Wednesday,...
SolarWinds Empowers IT Professionals with the Ultimate Hybrid IT Performance Management Platform
Mar 15, 2017 10:30 am UTC| Business
SYDNEY, Australia, March 15, 2017 -- SolarWinds, a leading provider of powerful and affordable IT management software, today revealed its latest capabilities for end-to-end hybrid IT management through key updates to...
SolarWinds Empowers IT Professionals with the Ultimate Hybrid IT Performance Management Platform
Mar 15, 2017 10:30 am UTC| Business
SYDNEY, Australia, March 15, 2017 -- SolarWinds, a leading provider of powerful and affordable IT management software, today revealed its latest capabilities for end-to-end hybrid IT management through key updates to...
SolarWinds Empowers IT Professionals with the Ultimate Hybrid IT Performance Management Platform
Mar 15, 2017 10:30 am UTC| Business
AUSTIN, Texas, March 15, 2017 -- SolarWinds, a leading provider of powerful and affordable IT management software, today revealed its latest capabilities for end-to-end hybrid IT management through key updates to its...
Affimed to Present at the Oppenheimer 27th Annual Healthcare Conference - New York
Mar 15, 2017 10:26 am UTC| Business
** Corrected Presentation Time ** Heidelberg, Germany, March 14, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer...